HIV: 2018 Pipeline Highlights – ResearchAndMarkets.com


DUBLIN–()–The “HIV
Pipeline Highlights – 2018”
report has been added to ResearchAndMarkets.com’s
offering.

HIV Pipeline Highlights – 2018, provides the most up-to-date information
on key pipeline products in the global HIV market.

It covers emerging therapies for HIV in active clinical development
stages including early and late stage clinical trials. The pipeline data
presented in this report helps executives for tracking competition,
identifying partners, evaluating opportunities, formulating business
development strategies, and executing in-licensing and out-licensing
deals.

Clinical Trial Stages

The report provides HIV pipeline products by clinical trial stages
including both early and late stage development – phase 3 clinical
trials, phase 2 clinical trials, phase 1 clinical trials, preclinical
research, and discovery stage.

Drug Mechanism Classes

The report provides HIV pipeline products by their dominant mechanism of
action. This helps executives categorize products based on their drug
class and also assess the strengths and weaknesses of compounds.

Company

The report provides HIV pipeline products by the company.

Short-term Launch Highlights

Find out which HIV pipeline products will be launched in the US and
Ex-US till 2020.

For more information about this report visit https://www.researchandmarkets.com/research/q3gvjh/hiv_2018?w=4



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *